No Data
No Data
Astrana Health Initiated at Outperform by Baird
Astrana Health Initiated at Outperform by Baird
Express News | Baird Initiates Coverage On Astrana Health With Outperform Rating, Announces Price Target of $54
Those Who Invested in Astrana Health (NASDAQ:ASTH) Five Years Ago Are up 153%
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. One great example is
Astrana Health, Inc. to Participate in Upcoming Investor Conferences
ALHAMBRA, Calif., May 28, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric,
Astrana Health Shares Financial Overview With Investors
Express News | Astrana Health : Reiterates Guidance for 2024
No Data